CNR2 and schizophrenia: Subsequent studies characterized CB2 expression in the brain [7,8,9,10], and the CB2 receptor has emerged as a therapeutic target for brain disorders ranging from anxiety [11] and depression [12] to addiction [13] and schizophrenia [14,15].